We found similar, mostly significant results for the other subtypes of breast cancer (Luminal B: threshold = 4,5 FPKM, ARHGAP29lown = 72, ARHGAP29highn = 125; p = 0.0445; human epidermal growth factor receptor 2 overexpression (HER2+): threshold = 9 FPKM, ARHGAP29lown = 59, ARHGAP29highn = 15, p = 0.0343; Basal: threshold = 8 FPKM, ARHGAP29lown = 109, ARHGAP29highn = 48, p = 0.0505; not shown). This evidence concerns the gene ERBB2 and breast cancer.